We are thrilled to announce that AbbVie has successfully raised $250 million in a recent funding round. AbbVie is a leading global biopharmaceutical company dedicated to developing innovative medicines that prioritize making a positive impact on patients, communities, and the world. Specializing in areas such as immunology, oncology, neuroscience, eye care, and aesthetics, AbbVie strives to address challenging health issues and improve the quality of life for individuals worldwide. With this new infusion of funds, AbbVie aims to further advance its research and development efforts, bringing cutting-edge treatments and solutions to those in need. To learn more about AbbVie and its mission-driven approach to healthcare, visit www.abbvie.com and explore the company's commitment to fostering a supportive and inclusive online community at https://www.abbvie.com/social-media-community-guidelines.html.
AbbVie Secures $250 Million in Funding to Drive Impactful Health Solutions
Recently funded 路 $250.0MPharmaceuticals
Get the full AbbVie company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Lane
Lane is the world鈥檚 leading workplace experience platform. Founded in 2014 to transform and connect the workplace, our no-code enterprise software streamlines all aspects of day-to-day office life鈥攆rom room bookings and access management, to communications and commerce, to events, data, and beyond. Our award-winning mobile and web technology is built to scale, allowing workplace providers to deploy globally and configure locally. Powering 300+ properties across 22 major cities in 8 countries, Lane clients include Brookfield, Oxford, Colliers, Dream, Nuveen, Studio by Tishman Speyer, and more. Putting all of the pieces together, Lane turns any workplace into a place that works. www.joinlane.com www.twitter.com/joinlane www.instagram.com/join_lane
$1.0M Pre-seed
today
Clarity Systems
AI for Retail Returns
$4.4M Seed
today
